Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. The company is headquartered in Wuxi, Jiangsu and currently employs 12,552 full-time employees. The company went IPO on 2017-06-13. The firm mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The firm mainly conducts its business in the domestic and overseas markets.
02269.HK stock price ended at $41.34 on 목요일, after dropping 0.14%
On the latest trading day Feb 12, 2026, the stock price of 02269.HK fell by 0.14%, dropping from $42.52 to $41.34. During the session, the stock saw a volatility of 8.21%, with prices oscillating between a daily low of $40.66 and a high of $44.00. On the latest trading day, the trading volume for 02269.HK rose by 39.0M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 73.5M shares were traded, with a market value of approximately $170.6B.
02269.HK 기술적 시그널
기술적 시그널 요약
구매 신호 4
중립 신호 0
매도 신호 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
02269.HK은 현재 4개의 매수 신호와 3개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -0.14%입니다. 전반적으로 기술적 지표들은 중기적으로 Buy 전망을 나타내고 있습니다.
02269.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 02269.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.